Arizona Liver Health(@LiverArizona) 's Twitter Profile Photo

Join Dr. Naim Alkhouri, MD, at Innovations in SLD Think-Tank 2024! This dynamic two-day event brings together experts in endocrinology, gastroenterology, hepatology, and primary care. Let's bridge diagnostic gaps together on May 3, 2024.

Join Dr. Naim Alkhouri, MD, at Innovations in SLD Think-Tank 2024! This dynamic two-day event brings together experts in endocrinology, gastroenterology, hepatology, and primary care. Let's bridge diagnostic gaps together on May 3, 2024. #SLDThinkTank
account_circle
Robert G. Gish(@RobertGish) 's Twitter Profile Photo

The SLD Think-Tank will host great faculty at a fabulous location with the highest quality data. Focus on interaction, learning from each other & evolving the multidisciplinary field. Mark your calendar + register here: virology.eventsair.com/sld2024/endors…

The SLD Think-Tank will host great faculty at a fabulous location with the highest quality data. Focus on interaction, learning from each other & evolving the multidisciplinary field. Mark your calendar + register here: virology.eventsair.com/sld2024/endors…
#LiverTwitter #INCBCN #SLDThinkTank
account_circle
Elliot Tapper(@ebtapper) 's Twitter Profile Photo

Should we screen for advanced fibrosis?

Yes. According to multiple professional societies

But. False positives and false negatives are problematic

So. Test higher risk people (eg diabetes) using two-steps

Should we screen for advanced fibrosis?

Yes. According to multiple professional societies

But. False positives and false negatives are problematic

So. Test higher risk people (eg diabetes) using two-steps

#sldthinktank
account_circle
AASLD(@AASLDtweets) 's Twitter Profile Photo

Be a part of groundbreaking discussions at the in Barcelona, Spain. Explore cutting-edge discussions on Care, earn credits, & be part of the change. Register today: virology.eventsair.com/sld2024/endors…

Be a part of groundbreaking discussions at the #SLDThinkTank in Barcelona, Spain. Explore cutting-edge discussions on #MASLD Care, earn #CME credits, & be part of the change. Register today: virology.eventsair.com/sld2024/endors…
account_circle
Academic Medical Education(@Academic_MedEdu) 's Twitter Profile Photo

Drs. Jeffrey V. Lazarus & Jörn Schattenberg invite you to the exclusive Innovations in in Barcelona, Spain!

Explore cutting-edge discussions on Care, earn credits, & be part of the change.

Don’t miss out, register here 👉 amededu.co/3T8IhHd

account_circle
Academic Medical Education(@Academic_MedEdu) 's Twitter Profile Photo

As 1.5 billion people worldwide suffer from chronic , we advocate for education & fair access to liver care.

At the upcoming , we’ll bridge science into actionable diagnosis, prevention, & treatment strategies: amededu.co/3QbajkF

As 1.5 billion people worldwide suffer from chronic #liverdisease, we advocate for education & fair access to liver care.

At the upcoming #SLDThinkTank, we’ll bridge science into actionable diagnosis, prevention, & treatment strategies: amededu.co/3QbajkF

#WorldLiverDay
account_circle
Academic Medical Education(@Academic_MedEdu) 's Twitter Profile Photo

The 3rd edition of the ThinkTank , including the , was successfully convened from 3-4 May in Barcelona, Spain!

Thanks to our faculty, sponsors, & delegates for their invaluable support & participation in this meeting!

Jeffrey V. Lazarus Jörn Schattenberg Dídac Mauricio

The 3rd edition of the #SLDThinkTank, including the #NITsummit, was successfully convened from 3-4 May in Barcelona, Spain!

Thanks to our faculty, sponsors, & delegates for their invaluable support & participation in this meeting!

#SLD @JVLazarus @schattenbergJ @DidacMauricio
account_circle
Jeffrey V. Lazarus(@JVLazarus) 's Twitter Profile Photo

On , with just behind us, we ask World Health Organization (WHO) to address MASLD and MASH as a public health priority on par with other NCDs:
MASLD/MASH research priorities:
journal-of-hepatology.eu/article/S0168-…

Action priorities:
journals.lww.com/hep/fulltext/9…

On #WorldHealthDay2024, with #LiverConnect just behind us, we ask @WHO to address MASLD and MASH as a public health priority on par with other NCDs:
MASLD/MASH research priorities:
journal-of-hepatology.eu/article/S0168-…

Action priorities:
journals.lww.com/hep/fulltext/9…
#LiverTwitter #SLDthinktank
account_circle
Jeffrey V. Lazarus(@JVLazarus) 's Twitter Profile Photo

Academic Medical Education Jörn Schattenberg 1. ⏱ The countdown begins!⏱

In less than 5 hours we’ll be joining a community of hepatologists, endocrinologists, patient advocates and many more from across disciplines to debate steatotic liver disease at the Innovations in 2024.

🧵Thread below

@Academic_MedEdu @schattenbergJ 1. ⏱ The countdown begins!⏱

In less than 5 hours we’ll be joining a community of hepatologists, endocrinologists, patient advocates and many more from across disciplines to debate steatotic liver disease at the Innovations in #SLDThinkTank 2024.

🧵Thread below

#LiverTwitter
account_circle
Jeffrey V. Lazarus(@JVLazarus) 's Twitter Profile Photo

I was inspired by Elliot Tapper - photo from the Innovations in , held annually in Barcelona and co-chaired w Jörn Schattenberg (sitting next to me in the photo and now in Rize). Also, it's my 20,000th day on earth, inspired by Nick Cave & The Bad Seeds to celebrate it...!

I was inspired by @ebtapper - photo from the Innovations in #SLDThinktank, held annually in Barcelona and co-chaired w @schattenbergJ (sitting next to me in the photo and now in Rize). Also, it's my 20,000th day on earth, inspired by @nickcave to celebrate it...!
#LiverTwitter
account_circle
FattyLiverAlliance(@FattyLiverA) 's Twitter Profile Photo

Always great being part of these important discussions and the was an exceptional opportunity for open dialogue and the sharing of creative solutions to a global challenge - Steatotic Liver Disease.

EASLnews AASLD ISGlobal CASL Canadian NASH Network

account_circle
Elliot Tapper(@ebtapper) 's Twitter Profile Photo

How do we spread awareness of a common liver disease

Everyone knows about the liver in the context of alcohol

But steatotic / fatty liver?

What is the bridge to generalized awareness? What’s the branding?

account_circle
Jeffrey V. Lazarus(@JVLazarus) 's Twitter Profile Photo

Diego Schwarzstein Yes, and here are the next steps
'Opportunities and challenges following approval of resmetirom for MASH liver disease' being discussed in the Círculo Ecuestre in Barcelona at
nature.com/articles/s4159… Nature Medicine

account_circle